Lannett Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
May 02,2023: Lannett Files Prepackaged Chapter 11 Cases to Significantly Strengthen Financial Position
May 01,2023: Lannett Company enters into restructuring support agreement
Apr 04,2023: Lannett Provides Financial Update
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Lannett Co Inc (Lannett) develops, manufactures, packages, markets, and distributes generic brand pharmaceutical products in tablet, capsule, and oral liquid forms. The company provides generic pharmaceuticals for medical indications such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious diseases, migraine, respiratory, urinary, and others. Lannett also offers laboratory services, product formulation, and development services, and packaging solid dosage forms. Lannett sells pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, and health maintenance organizations. Lannett is headquartered in Trevose, Pennsylvania, the US.Lannett Co Inc Key Recent Developments
Jun 16,2023: Lannett Successfully Emerges From Chapter 11 in Significantly Stronger Financial Position as the Company Remains on Track Toward Commercialization of Highly Promising PipelineMay 02,2023: Lannett Files Prepackaged Chapter 11 Cases to Significantly Strengthen Financial Position
May 01,2023: Lannett Company enters into restructuring support agreement
Apr 04,2023: Lannett Provides Financial Update
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company’s Lifesciences Financial Deals and Alliances
Section 4 - Company’s Recent Developments
Section 5 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mallinckrodt LLC
- GSK plc
- Par Pharmaceutical Holdings Inc
- Sandoz Inc
- Dr. Reddy's Laboratories Inc
- Pharming Group NV
- Aurobindo Pharma USA Inc
- Mylan Delaware Inc.
- Dr. Reddy's Laboratories Inc
- Pharming Group NV
- Aurobindo Pharma USA Inc
- Mallinckrodt LLC
- GSK plc
- Sandoz Inc
- Par Pharmaceutical Holdings Inc
- Mylan Delaware Inc.